| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL5A3 COL24A1 | 7.04e-14 | 46 | 112 | 10 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL5A3 COL24A1 | 1.06e-07 | 188 | 112 | 10 | GO:0005201 |
| GeneOntologyCellularComponent | collagen trimer | COL4A3 COL4A6 C1QTNF8 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 SFTPD C1QTNF9B COL5A3 COL24A1 C1QTNF9 | 5.64e-19 | 88 | 110 | 15 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 7.00e-08 | 21 | 110 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 CANX COL5A3 COL24A1 | 1.85e-07 | 332 | 110 | 12 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 SFTPD COL5A3 COL24A1 | 2.30e-05 | 530 | 110 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | anchoring collagen complex | 8.20e-05 | 3 | 110 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | main axon | 1.08e-04 | 89 | 110 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 SFTPD COL5A3 COL24A1 | 1.76e-04 | 656 | 110 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 SFTPD COL5A3 COL24A1 | 1.81e-04 | 658 | 110 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | postsynapse | CUL3 GAP43 CANX TPPP EPB41L3 PICALM ADAM22 PRR12 KCNC2 NAPB KCNJ4 AFDN DGCR8 AKAP1 ATP2B1 | 2.86e-04 | 1018 | 110 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 4.06e-04 | 6 | 110 | 2 | GO:0005850 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 4.06e-04 | 6 | 110 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 4.06e-04 | 6 | 110 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | neuronal cell body | MYO1A COPA GAP43 CANX PICALM ITPR3 KCNC2 KCNJ4 PVALB MAST1 KCNQ3 ATP2B1 CNGA3 | 4.46e-04 | 835 | 110 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | axon initial segment | 4.69e-04 | 29 | 110 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 7.53e-04 | 8 | 110 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 7.53e-04 | 8 | 110 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 7.53e-04 | 8 | 110 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 7.67e-04 | 78 | 110 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | axon | MYO1A COPA GAP43 CANX EPB41L3 ADAM22 KCNC2 AVIL PVALB MAST1 KCNQ3 AFDN CNGA3 | 8.16e-04 | 891 | 110 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | cell body | MYO1A COPA GAP43 CANX PICALM ITPR3 KCNC2 KCNJ4 PVALB MAST1 KCNQ3 ATP2B1 CNGA3 | 1.19e-03 | 929 | 110 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.75e-03 | 12 | 110 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.75e-03 | 12 | 110 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MYO1A COPA GAP43 FAT3 CANX PICALM ITPR3 KCNC2 KCNJ4 PVALB MAST1 KCNQ3 AFDN ATP2B1 CNGA3 | 1.93e-03 | 1228 | 110 | 15 | GO:0036477 |
| MousePheno | decreased dentate gyrus size | 1.56e-05 | 8 | 93 | 3 | MP:0012460 | |
| MousePheno | abnormal corpus callosum morphology | 2.37e-05 | 129 | 93 | 7 | MP:0000780 | |
| MousePheno | abnormal dorsal telencephalic commissure morphology | 2.75e-05 | 132 | 93 | 7 | MP:0008219 | |
| MousePheno | abnormal nervous system tract morphology | 3.68e-05 | 189 | 93 | 8 | MP:0000778 | |
| MousePheno | abnormal brain white matter morphology | 6.77e-05 | 206 | 93 | 8 | MP:0008026 | |
| MousePheno | abnormal brain commissure morphology | 9.74e-05 | 161 | 93 | 7 | MP:0002199 | |
| Domain | Collagen | COL4A3 COL4A6 C1QTNF8 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 SFTPD C1QTNF9B COL5A3 COL24A1 C1QTNF9 | 1.69e-18 | 85 | 110 | 15 | IPR008160 |
| Domain | Collagen | COL4A3 COL4A6 C1QTNF8 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 SFTPD C1QTNF9B COL5A3 COL24A1 C1QTNF9 | 1.69e-18 | 85 | 110 | 15 | PF01391 |
| Domain | TSPN | 3.38e-09 | 23 | 110 | 6 | SM00210 | |
| Domain | Laminin_G | 4.76e-08 | 58 | 110 | 7 | IPR001791 | |
| Domain | - | 8.89e-08 | 95 | 110 | 8 | 2.60.120.200 | |
| Domain | NC1_FIB | 3.17e-05 | 11 | 110 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 3.17e-05 | 11 | 110 | 3 | PD002078 | |
| Domain | Fib_collagen_C | 3.17e-05 | 11 | 110 | 3 | IPR000885 | |
| Domain | COLFI | 3.17e-05 | 11 | 110 | 3 | PF01410 | |
| Domain | COLFI | 3.17e-05 | 11 | 110 | 3 | SM00038 | |
| Domain | ConA-like_dom | 4.62e-05 | 219 | 110 | 8 | IPR013320 | |
| Domain | Laminin_G_2 | 8.84e-05 | 40 | 110 | 4 | PF02210 | |
| Domain | TUDOR | 3.23e-04 | 23 | 110 | 3 | PS50304 | |
| Domain | C4 | 5.08e-04 | 6 | 110 | 2 | SM00111 | |
| Domain | Collagen_VI_NC | 5.08e-04 | 6 | 110 | 2 | IPR001442 | |
| Domain | NC1_IV | 5.08e-04 | 6 | 110 | 2 | PS51403 | |
| Domain | - | 5.08e-04 | 6 | 110 | 2 | 2.170.240.10 | |
| Domain | C4 | 5.08e-04 | 6 | 110 | 2 | PF01413 | |
| Domain | TUDOR | 5.25e-04 | 27 | 110 | 3 | SM00333 | |
| Domain | Tudor | 7.19e-04 | 30 | 110 | 3 | IPR002999 | |
| Domain | C1Q | 8.71e-04 | 32 | 110 | 3 | SM00110 | |
| Domain | C1q | 8.71e-04 | 32 | 110 | 3 | PF00386 | |
| Domain | C1q_dom | 1.04e-03 | 34 | 110 | 3 | IPR001073 | |
| Domain | C1Q | 1.04e-03 | 34 | 110 | 3 | PS50871 | |
| Domain | PDZ | 1.48e-03 | 141 | 110 | 5 | PF00595 | |
| Domain | PDZ | 1.83e-03 | 148 | 110 | 5 | SM00228 | |
| Domain | PHD | 1.89e-03 | 89 | 110 | 4 | SM00249 | |
| Domain | - | 1.95e-03 | 150 | 110 | 5 | 2.30.42.10 | |
| Domain | PDZ | 2.00e-03 | 151 | 110 | 5 | PS50106 | |
| Domain | Znf_PHD | 2.05e-03 | 91 | 110 | 4 | IPR001965 | |
| Domain | PDZ | 2.06e-03 | 152 | 110 | 5 | IPR001478 | |
| Domain | LamG | 2.21e-03 | 44 | 110 | 3 | SM00282 | |
| Domain | ZF_PHD_2 | 2.40e-03 | 95 | 110 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.50e-03 | 96 | 110 | 4 | PS01359 | |
| Domain | TUDOR | 2.99e-03 | 14 | 110 | 2 | PF00567 | |
| Domain | - | 3.19e-03 | 50 | 110 | 3 | 2.60.120.40 | |
| Domain | VWA | 4.39e-03 | 56 | 110 | 3 | PF00092 | |
| Domain | Ion_trans_dom | 4.63e-03 | 114 | 110 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.63e-03 | 114 | 110 | 4 | PF00520 | |
| Domain | Tumour_necrosis_fac-like_dom | 4.85e-03 | 58 | 110 | 3 | IPR008983 | |
| Domain | - | 4.95e-03 | 18 | 110 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 4.95e-03 | 18 | 110 | 2 | IPR020901 | |
| Domain | BPTI_KUNITZ_1 | 5.51e-03 | 19 | 110 | 2 | PS00280 | |
| Domain | BPTI_KUNITZ_2 | 5.51e-03 | 19 | 110 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 5.51e-03 | 19 | 110 | 2 | PF00014 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 1.67e-15 | 44 | 87 | 11 | M27812 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 | 4.51e-14 | 41 | 87 | 10 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 2.50e-13 | 67 | 87 | 11 | M26999 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 | 3.29e-12 | 61 | 87 | 10 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 | 5.44e-12 | 64 | 87 | 10 | M26953 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 7.22e-12 | 90 | 87 | 11 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A3 COL4A6 COL6A3 COL7A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 | 3.02e-11 | 53 | 87 | 9 | MM14566 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 | 3.23e-11 | 76 | 87 | 10 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL5A3 COL24A1 | 1.14e-10 | 61 | 87 | 9 | M27103 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.59e-10 | 50 | 87 | 8 | MM14796 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.18e-08 | 46 | 87 | 7 | M198 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 | 1.41e-08 | 140 | 87 | 10 | M587 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A3 COL4A6 COL6A3 COL7A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 | 3.25e-08 | 114 | 87 | 9 | MM14571 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 3.44e-07 | 74 | 87 | 7 | M160 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 2.25e-06 | 300 | 87 | 11 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 | 4.11e-06 | 258 | 87 | 10 | MM14572 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.08e-06 | 20 | 87 | 4 | MM15061 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.18e-06 | 76 | 87 | 6 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.37e-05 | 85 | 87 | 6 | M16441 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.26e-05 | 32 | 87 | 4 | MM14924 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.30e-05 | 66 | 87 | 5 | M18 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 6.86e-05 | 36 | 87 | 4 | M39831 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.51e-05 | 38 | 87 | 4 | MM14969 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 9.79e-05 | 15 | 87 | 3 | M27161 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.04e-04 | 76 | 87 | 5 | M27219 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.27e-04 | 42 | 87 | 4 | M7169 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.17e-04 | 57 | 87 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.45e-04 | 58 | 87 | 4 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.76e-04 | 59 | 87 | 4 | M27218 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.11e-04 | 63 | 87 | 4 | M11187 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.17e-04 | 30 | 87 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.17e-04 | 30 | 87 | 3 | M27216 | |
| Pathway | WP_GLIAL_CELL_DIFFERENTIATION | 1.03e-03 | 8 | 87 | 2 | M39372 | |
| Pathway | REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE | 1.03e-03 | 8 | 87 | 2 | M27169 | |
| Pathway | WP_MIRNAS_AND_TFS_IN_IPS_CELL_GENERATION | 1.03e-03 | 8 | 87 | 2 | MM15855 | |
| Pathway | WP_METHYLATION_PATHWAYS | 1.32e-03 | 9 | 87 | 2 | M39493 | |
| Pathway | REACTOME_RECYCLING_OF_EIF2_GDP | 1.32e-03 | 9 | 87 | 2 | MM15418 | |
| Pathway | WP_METHYLATION | 1.32e-03 | 9 | 87 | 2 | MM15836 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.64e-03 | 10 | 87 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1560 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS | 1.64e-03 | 10 | 87 | 2 | MM17234 | |
| Pathway | BIOCARTA_EIF_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1394 | |
| Pathway | BIOCARTA_EIF2_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1469 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.79e-03 | 84 | 87 | 4 | M7098 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.00e-03 | 11 | 87 | 2 | M15422 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.04e-03 | 41 | 87 | 3 | M27778 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.39e-03 | 12 | 87 | 2 | MM1526 | |
| Pathway | REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR | 2.39e-03 | 12 | 87 | 2 | MM14981 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.81e-03 | 13 | 87 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.81e-03 | 13 | 87 | 2 | M12950 | |
| Pathway | REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN | 2.81e-03 | 13 | 87 | 2 | M27240 | |
| Pubmed | CUL3 COPA RSF1 CHD3 RABGAP1 BANF1 GMPS PPP1R8 SRRT MED4 SND1 ATG3 PRPF4 AHNAK NCAPD2 PRKDC NNMT TOP2B UBFD1 RAD21 | 8.48e-11 | 1014 | 112 | 20 | 32416067 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RSF1 EIF2S3B GPATCH4 CHD3 EPB41L3 PICALM SRRT DCD PRPF4 EIF2S3 AHNAK HNRNPA0 AFDN DGCR8 PRKDC DDX39B TOP2B RAI1 RAD21 | 2.26e-10 | 954 | 112 | 19 | 36373674 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RSF1 IST1 GPATCH4 CHD3 EPB41L3 PICALM GMPS KIAA1671 SND1 EIF2S3 AHNAK PRKDC AKAP1 TOP2B PRRC2B AHNAK2 UBFD1 RAD21 | 1.19e-09 | 934 | 112 | 18 | 33916271 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | COPA CANX PICALM SND1 ATG3 AHNAK PRKDC ATP2B1 DDX39B TOP2B AHNAK2 | 1.22e-09 | 268 | 112 | 11 | 33024031 |
| Pubmed | COPA CANX PICALM GMPS SND1 DCD PRPF4 EIF2S3 NCAPD2 HNRNPA0 DYNC1LI1 PRKDC DDX39B TOP2B RAD21 | 2.32e-09 | 638 | 112 | 15 | 33239621 | |
| Pubmed | COPA IST1 BANF1 ITPR3 KIAA1671 PPP1R8 SRRT SND1 PRPF4 EIF2S3 AHNAK HNRNPA0 PRKDC DDX39B TOP2B | 3.66e-09 | 660 | 112 | 15 | 32780723 | |
| Pubmed | CUL3 COPA GAP43 TPPP EIF2S3B CHD3 EPB41L3 ADAM22 SRRT NAPB SND1 EIF2S3 HNRNPA0 MAST1 KCNQ3 AFDN ACTL6B ALDH1B1 ATP2B1 DDX39B PRRC2B | 5.49e-09 | 1431 | 112 | 21 | 37142655 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | COPA CHD3 EPB41L3 PICALM DRG1 GMPS SND1 AHNAK NCAPD2 HNRNPA0 DYNC1LI1 PRKDC DDX39B RAD21 | 6.18e-09 | 582 | 112 | 14 | 20467437 |
| Pubmed | MYO1A COPA RSF1 HKDC1 CHD3 EPB41L3 ECE1 BANF1 PRX SND1 AHNAK AVIL NCAPD2 HNRNPA0 PRKDC ALDH1B1 ATP2B1 DDX39B TOP2B PRRC2B RAI1 | 6.27e-09 | 1442 | 112 | 21 | 35575683 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | COPA CHD3 SRRT SND1 AHNAK NCAPD2 HNRNPA0 PRKDC DDX39B AHNAK2 RAD21 | 1.13e-08 | 332 | 112 | 11 | 32786267 |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.42e-08 | 135 | 112 | 8 | 28675934 | |
| Pubmed | CUL3 CHD3 BANF1 DRG1 GMPS PRR12 MED4 SND1 DCD PRPF4 EIF2S3 HNRNPA0 DYNC1LI1 PRKDC TOP2B PRRC2B RAI1 RAD21 | 1.57e-08 | 1103 | 112 | 18 | 34189442 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CUL3 COPA GPATCH4 CHD3 DRG1 SRRT MED4 SND1 PRPF4 EIF2S3 DGCR8 PRKDC AKAP1 TOP2B RAD21 | 2.34e-08 | 759 | 112 | 15 | 35915203 |
| Pubmed | COPA CANX RSF1 EPB41L3 ITPR3 GMPS SND1 AHNAK NCAPD2 AFDN PRKDC PRRC2B RAI1 RAD21 | 2.61e-08 | 653 | 112 | 14 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | COPA CANX GPATCH4 EPB41L3 DRG1 SRRT SND1 DCD PRPF4 EIF2S3 NCAPD2 HNRNPA0 DYNC1LI1 AFDN PRKDC ALDH1B1 ATP2B1 DDX39B TOP2B RAD21 | 2.79e-08 | 1425 | 112 | 20 | 30948266 |
| Pubmed | COL4A3 COL4A6 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 HKDC1 COL5A3 | 2.88e-08 | 210 | 112 | 9 | 16537572 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | COPA CANX SUN1 CHD3 DRG1 ITPR3 KIAA1671 SRRT SND1 PRPF4 AHNAK HNRNPA0 AFDN PRKDC ATP2B1 DDX39B TOP2B | 3.21e-08 | 1024 | 112 | 17 | 24711643 |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 21940993 | ||
| Pubmed | 3.77e-08 | 153 | 112 | 8 | 25037231 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | COPA RSF1 GPATCH4 EPB41L3 GMPS SRRT SND1 DCD AHNAK NCAPD2 HNRNPA0 DYNC1LI1 AFDN PRKDC ALDH1B1 ATP2B1 DDX39B TOP2B AHNAK2 | 6.44e-08 | 1353 | 112 | 19 | 29467282 |
| Pubmed | COPA IST1 PICALM DRG1 GMPS SND1 PRPF4 EIF2S3 AHNAK HNRNPA0 AFDN PRKDC ALDH1B1 DDX39B | 6.95e-08 | 707 | 112 | 14 | 19738201 | |
| Pubmed | 1.07e-07 | 175 | 112 | 8 | 28071719 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | COPA CANX SUN1 SRRT SND1 USP42 DCD EIF2S3 AHNAK HNRNPA0 DGCR8 PRKDC ALDH1B1 DDX39B TOP2B RAD21 | 1.20e-07 | 989 | 112 | 16 | 36424410 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | COPA CANX EIF2S3B GPATCH4 DRG1 GMPS SRRT SND1 DCD PRPF4 EIF2S3 AHNAK NCAPD2 HNRNPA0 PRKDC DDX39B TOP2B AHNAK2 RAD21 | 1.29e-07 | 1415 | 112 | 19 | 28515276 |
| Pubmed | CTRP8 and CTRP9B are novel proteins that hetero-oligomerize with C1q/TNF family members. | 1.30e-07 | 4 | 112 | 3 | 19666007 | |
| Pubmed | COPA CANX CHD3 EPB41L3 DRG1 GMPS SRRT DCD EIF2S3 NCAPD2 HNRNPA0 PRKDC TOP2B | 1.61e-07 | 641 | 112 | 13 | 36057605 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ERF COPA GPATCH4 CHD3 BANF1 ITPR3 PRR12 SRRT MED4 USP42 PRPF4 AHNAK HNRNPA0 PRKDC DDX39B TOP2B RAI1 RAD21 | 1.72e-07 | 1294 | 112 | 18 | 30804502 |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | ERF TSHZ2 CANX TPPP HKDC1 CHD3 PICALM OTUD7B PPP1R8 MED4 HOXC6 DMKN HNRNPA0 RUSC1-AS1 AKAP1 ATP2B1 | 1.85e-07 | 1021 | 112 | 16 | 26760575 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL3 COPA IST1 RABGAP1 GMPS SRRT SND1 ATG3 PRPF4 EIF2S3 AHNAK NCAPD2 HNRNPA0 DYNC1LI1 PRKDC ALDH1B1 DDX39B AHNAK2 UBFD1 | 1.98e-07 | 1455 | 112 | 19 | 22863883 |
| Pubmed | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. | 2.17e-07 | 192 | 112 | 8 | 32176739 | |
| Pubmed | CUL3 COPA CANX DRG1 SRRT SND1 DCD EIF2S3 AHNAK NCAPD2 HNRNPA0 DYNC1LI1 PRKDC NLRC3 | 3.56e-07 | 809 | 112 | 14 | 32129710 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | COPA CANX IST1 RABGAP1 AKR1A1 EPB41L3 DRG1 GMPS SND1 DCD AHNAK NCAPD2 AFDN PRKDC NNMT PRRC2B AHNAK2 RAD21 | 3.83e-07 | 1367 | 112 | 18 | 32687490 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | COPA CANX HKDC1 CHD3 RABGAP1 BANF1 EIF2S3 NCAPD2 HNRNPA0 DYNC1LI1 PRKDC ATP2B1 DDX39B UBFD1 | 6.14e-07 | 847 | 112 | 14 | 35235311 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | CANX GPATCH4 CHD3 SRRT SND1 DCD PRPF4 HNRNPA0 PRKDC DDX39B TOP2B RAI1 | 6.26e-07 | 605 | 112 | 12 | 28977666 |
| Pubmed | CUL3 COPA CANX GPATCH4 DRG1 SRRT EIF2S3 HNRNPA0 DYNC1LI1 PRKDC ALDH1B1 ATP2B1 DDX39B | 6.46e-07 | 725 | 112 | 13 | 27025967 | |
| Pubmed | COPA CANX PICALM BANF1 ITPR3 KIAA1671 SND1 EIF2S3 AHNAK NCAPD2 HNRNPA0 DYNC1LI1 PRKDC ALDH1B1 ATP2B1 TOP2B PRRC2B AHNAK2 | 8.11e-07 | 1440 | 112 | 18 | 30833792 | |
| Pubmed | 1.23e-06 | 167 | 112 | 7 | 22159717 | ||
| Pubmed | COL4A3 ERF GPATCH4 EPB41L3 OTUD7B KIAA1671 EIF2S3 AHNAK AFDN DGCR8 PRKDC AKAP1 PRRC2B | 1.39e-06 | 777 | 112 | 13 | 35844135 | |
| Pubmed | COPA CANX IST1 PICALM BANF1 SRRT SND1 DCD ATG3 PRPF4 DYNC1LI1 DDX39B TOP2B | 1.58e-06 | 786 | 112 | 13 | 29128334 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.77e-06 | 62 | 112 | 5 | 28344315 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | IST1 EPB41L3 PICALM KIAA1671 SND1 EIF2S3 AHNAK AFDN ATP2B1 DDX39B UBFD1 | 2.26e-06 | 565 | 112 | 11 | 25468996 |
| Pubmed | MFHAS1 SUN1 RABGAP1 EPB41L3 ITPR3 PIGC ATG3 AHNAK AKAP1 AHNAK2 UBFD1 | 2.37e-06 | 568 | 112 | 11 | 37774976 | |
| Pubmed | CUL3 COL12A1 CANX RSF1 IST1 PICALM OTUD7B COL24A1 ZNHIT6 USP42 PRRC2B ZNF646 | 2.41e-06 | 689 | 112 | 12 | 36543142 | |
| Pubmed | 2.59e-06 | 267 | 112 | 8 | 33417871 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CUL3 COPA CANX DRG1 ITPR3 KIAA1671 SRRT SND1 DCD PRPF4 EIF2S3 AHNAK HNRNPA0 PRKDC DDX39B RAD21 | 2.81e-06 | 1257 | 112 | 16 | 36526897 |
| Pubmed | ERF FAT3 RSF1 GPATCH4 CHD3 EPB41L3 DRG1 KIAA1671 ZNHIT6 PRPF4 FMN2 ACTL6B PRRC2B RAI1 ZNF646 | 3.08e-06 | 1116 | 112 | 15 | 31753913 | |
| Pubmed | COPA CANX DRG1 ITPR3 SRRT PRPF4 EIF2S3 HNRNPA0 AFDN PRKDC ALDH1B1 DDX39B | 3.33e-06 | 711 | 112 | 12 | 33022573 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.35e-06 | 202 | 112 | 7 | 33005030 | |
| Pubmed | 4.35e-06 | 202 | 112 | 7 | 24639526 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | CUL3 COPA CANX AKR1A1 BANF1 DRG1 GMPS SND1 EIF2S3 AHNAK NCAPD2 DYNC1LI1 AFDN PRKDC DDX39B | 4.38e-06 | 1149 | 112 | 15 | 35446349 |
| Pubmed | 4.50e-06 | 491 | 112 | 10 | 22623428 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL3 COPA CANX GPATCH4 PPP1R8 ZNHIT6 PRPF4 AHNAK HNRNPA0 DYNC1LI1 PRKDC DDX39B TOP2B PRRC2B RAD21 | 4.66e-06 | 1155 | 112 | 15 | 20360068 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | COPA CANX GPATCH4 BANF1 DRG1 GMPS SND1 USP42 PRPF4 EIF2S3 AHNAK HNRNPA0 PRKDC DDX39B TOP2B RAD21 | 5.13e-06 | 1318 | 112 | 16 | 30463901 |
| Pubmed | CUL3 COPA CANX ECE1 PICALM DRG1 ITPR3 MED4 AHNAK NCAPD2 DYNC1LI1 PRKDC AKAP1 ATP2B1 RAD21 | 5.33e-06 | 1168 | 112 | 15 | 19946888 | |
| Pubmed | COPA CANX SUN1 BANF1 ITPR3 GMPS KIAA1671 PPP1R8 MED4 PRPF4 AHNAK FMN2 ATP2B1 PRRC2B | 7.31e-06 | 1049 | 112 | 14 | 27880917 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL3 COPA CHD3 OTUD7B SRRT USP42 DYNC1LI1 AFDN PRKDC AKAP1 TOP2B KDM4B | 7.85e-06 | 774 | 112 | 12 | 15302935 |
| Pubmed | CANX SUN1 ITPR3 SRRT DCD AHNAK HNRNPA0 PRKDC DDX39B TOP2B RAD21 | 8.76e-06 | 652 | 112 | 11 | 31180492 | |
| Pubmed | 9.03e-06 | 419 | 112 | 9 | 15635413 | ||
| Pubmed | 9.35e-06 | 534 | 112 | 10 | 35032548 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12087094 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25783894 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21836066 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24473438 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22972916 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 27188183 | ||
| Pubmed | Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina. | 1.03e-05 | 2 | 112 | 2 | 35575905 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 30426302 | ||
| Pubmed | CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells. | 1.03e-05 | 2 | 112 | 2 | 29749459 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15007166 | ||
| Pubmed | CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages. | 1.03e-05 | 2 | 112 | 2 | 31837806 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 28978553 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 32283037 | ||
| Pubmed | C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. | 1.03e-05 | 2 | 112 | 2 | 27821723 | |
| Pubmed | Identification of a tandem duplicated array in the Rhox alpha locus on mouse chromosome X. | 1.03e-05 | 2 | 112 | 2 | 16465597 | |
| Pubmed | Cloning and characterization of the 5'-flanking region of the Ehox gene. | 1.03e-05 | 2 | 112 | 2 | 16414020 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 35008006 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24030394 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 36766785 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 37945738 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22514273 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 38741428 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 30764693 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 9143499 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 29145717 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 20833135 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26419929 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 9202028 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 32831639 | ||
| Pubmed | Rhox homeobox gene cluster: recent duplication of three family members. | 1.03e-05 | 2 | 112 | 2 | 16496311 | |
| Pubmed | CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet. | 1.03e-05 | 2 | 112 | 2 | 38940054 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26754066 | ||
| Pubmed | CTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux. | 1.03e-05 | 2 | 112 | 2 | 33352225 | |
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 1.03e-05 | 2 | 112 | 2 | 16325480 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.04e-05 | 231 | 112 | 7 | 36597993 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | COPA CANX EIF2S3B GPATCH4 ITPR3 ZNHIT6 SND1 DCD EIF2S3 AHNAK HNRNPA0 PRKDC DDX39B | 1.21e-05 | 949 | 112 | 13 | 36574265 |
| Pubmed | 1.23e-05 | 237 | 112 | 7 | 29564676 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CUL3 COPA CANX EIF2S3B DRG1 GMPS ZNHIT6 SND1 DCD EIF2S3 HNRNPA0 DYNC1LI1 PRKDC ALDH1B1 DDX39B | 1.27e-05 | 1257 | 112 | 15 | 37317656 |
| Pubmed | 1.27e-05 | 332 | 112 | 8 | 37433992 | ||
| Pubmed | 1.51e-05 | 340 | 112 | 8 | 29478914 | ||
| Pubmed | 1.51e-05 | 340 | 112 | 8 | 24332808 | ||
| Interaction | ACE2 interactions | COPA CANX CHD3 RABGAP1 EPB41L3 PICALM BANF1 CABLES1 DRG1 GMPS SRRT ZNHIT6 DCD EIF2S3 NCAPD2 HNRNPA0 MAST1 PRKDC DDX39B TOP2B PRRC2B AHNAK2 | 1.56e-07 | 1106 | 112 | 22 | int:ACE2 |
| Interaction | CIT interactions | CUL3 COPA CANX SUN1 RSF1 EIF2S3B GPATCH4 CHD3 AKR1A1 PICALM BANF1 DRG1 ITPR3 KIAA1671 SND1 DCD PRPF4 AHNAK HNRNPA0 PRKDC DDX39B TOP2B AHNAK2 RAD21 | 1.11e-06 | 1450 | 112 | 24 | int:CIT |
| Interaction | NAA40 interactions | CUL3 RSF1 IST1 GPATCH4 CHD3 EPB41L3 PICALM GMPS KIAA1671 SND1 EIF2S3 AHNAK PRKDC AKAP1 TOP2B PRRC2B AHNAK2 UBFD1 RAD21 | 1.76e-06 | 978 | 112 | 19 | int:NAA40 |
| Interaction | UHRF2 interactions | 1.77e-06 | 200 | 112 | 9 | int:UHRF2 | |
| Interaction | SMC5 interactions | RSF1 EIF2S3B GPATCH4 CHD3 EPB41L3 PICALM SRRT DCD PRPF4 EIF2S3 AHNAK HNRNPA0 AFDN DGCR8 PRKDC DDX39B TOP2B RAI1 RAD21 | 2.44e-06 | 1000 | 112 | 19 | int:SMC5 |
| Interaction | FN1 interactions | COL4A3 COL4A6 COL7A1 COL9A1 IST1 PICALM DRG1 GMPS SND1 PRPF4 EIF2S3 AHNAK HNRNPA0 AFDN PRKDC ALDH1B1 DDX39B | 4.36e-06 | 848 | 112 | 17 | int:FN1 |
| Interaction | SUMO2 interactions | CUL3 COPA CHD3 SRRT SND1 DCD AHNAK NCAPD2 HNRNPA0 PRKDC DDX39B TOP2B AHNAK2 RAD21 | 5.11e-06 | 591 | 112 | 14 | int:SUMO2 |
| Interaction | NUPR1 interactions | COPA IST1 BANF1 ITPR3 KIAA1671 PPP1R8 SRRT SND1 PRPF4 EIF2S3 AHNAK HNRNPA0 PRKDC DDX39B TOP2B | 5.72e-06 | 683 | 112 | 15 | int:NUPR1 |
| Interaction | PLOD3 interactions | 8.44e-06 | 183 | 112 | 8 | int:PLOD3 | |
| Interaction | STIP1 interactions | COPA CANX PICALM GMPS SND1 DCD PRPF4 EIF2S3 AHNAK NCAPD2 HNRNPA0 DYNC1LI1 PRKDC ALDH1B1 AKAP1 DDX39B TOP2B RAD21 | 1.06e-05 | 1006 | 112 | 18 | int:STIP1 |
| Interaction | METTL14 interactions | COL6A3 ERICH3 COPA CANX BANF1 DRG1 SND1 DCD AHNAK NCAPD2 PRKDC DDX39B TOP2B | 1.36e-05 | 558 | 112 | 13 | int:METTL14 |
| Interaction | WDR11 interactions | 1.59e-05 | 144 | 112 | 7 | int:WDR11 | |
| Interaction | EIF3C interactions | 1.63e-05 | 263 | 112 | 9 | int:EIF3C | |
| Interaction | POU5F1 interactions | COPA CHD3 ITPR3 SND1 USP42 AHNAK NCAPD2 DYNC1LI1 AFDN PRKDC TOP2B PRRC2B RAD21 | 2.19e-05 | 584 | 112 | 13 | int:POU5F1 |
| Interaction | HECTD1 interactions | CUL3 COPA GPATCH4 CHD3 EPB41L3 DRG1 SRRT MED4 SND1 PRPF4 EIF2S3 NCAPD2 DGCR8 PRKDC AKAP1 TOP2B RAD21 | 3.00e-05 | 984 | 112 | 17 | int:HECTD1 |
| Interaction | EFTUD2 interactions | CUL3 COPA CANX SUN1 GPATCH4 CHD3 DRG1 GMPS SRRT SND1 DCD PRPF4 EIF2S3 AHNAK NCAPD2 HNRNPA0 PRKDC DDX39B TOP2B AHNAK2 RAD21 | 4.32e-05 | 1449 | 112 | 21 | int:EFTUD2 |
| Interaction | DHX38 interactions | 4.63e-05 | 170 | 112 | 7 | int:DHX38 | |
| Interaction | ANAPC2 interactions | 4.94e-05 | 234 | 112 | 8 | int:ANAPC2 | |
| Interaction | CHD4 interactions | CUL3 CANX RSF1 CHD3 BANF1 SRRT DCD PRPF4 AHNAK NCAPD2 HNRNPA0 PRKDC DDX39B TOP2B RAI1 RAD21 | 6.12e-05 | 938 | 112 | 16 | int:CHD4 |
| Interaction | SIRT7 interactions | COPA CANX RSF1 EPB41L3 ITPR3 GMPS SND1 AHNAK NCAPD2 AFDN PRKDC PRRC2B RAI1 RAD21 | 6.54e-05 | 744 | 112 | 14 | int:SIRT7 |
| Interaction | SNW1 interactions | CUL3 COPA CHD3 RABGAP1 PICALM DRG1 SND1 PRPF4 AHNAK NCAPD2 HNRNPA0 PRKDC DDX39B RAD21 | 6.82e-05 | 747 | 112 | 14 | int:SNW1 |
| Interaction | KBTBD4 interactions | 6.83e-05 | 316 | 112 | 9 | int:KBTBD4 | |
| Interaction | KCTD13 interactions | CUL3 COPA GAP43 TPPP CHD3 EPB41L3 ADAM22 SRRT NAPB SND1 EIF2S3 HNRNPA0 MAST1 KCNQ3 AFDN ACTL6B ALDH1B1 ATP2B1 DDX39B PRRC2B | 7.78e-05 | 1394 | 112 | 20 | int:KCTD13 |
| Interaction | HOXC4 interactions | 8.60e-05 | 42 | 112 | 4 | int:HOXC4 | |
| Interaction | HDAC2 interactions | CUL3 COPA CANX CHD3 BANF1 PPP1R8 DCD PRPF4 AHNAK NCAPD2 PRKDC TOP2B RAI1 AHNAK2 RAD21 | 8.83e-05 | 865 | 112 | 15 | int:HDAC2 |
| Interaction | AMPD1 interactions | 8.88e-05 | 16 | 112 | 3 | int:AMPD1 | |
| Interaction | UNK interactions | CUL3 COPA PICALM KIAA1671 SND1 EIF2S3 ATP2B1 TOP2B PRRC2B RAD21 | 9.35e-05 | 408 | 112 | 10 | int:UNK |
| Interaction | ISG15 interactions | COPA CANX IST1 PICALM SND1 AHNAK PRKDC ATP2B1 DDX39B TOP2B AHNAK2 | 9.71e-05 | 494 | 112 | 11 | int:ISG15 |
| Interaction | ASB3 interactions | 1.05e-04 | 84 | 112 | 5 | int:ASB3 | |
| Interaction | MTNR1B interactions | 1.08e-04 | 135 | 112 | 6 | int:MTNR1B | |
| Interaction | AKAP1 interactions | CUL3 TMEM67 CANX SUN1 CABLES1 DRG1 ITPR3 EIF2S3 NCAPD2 AKAP1 ATP2B1 | 1.14e-04 | 503 | 112 | 11 | int:AKAP1 |
| Interaction | ECT2 interactions | MYO1A COPA GPATCH4 PICALM BANF1 KIAA1671 PRR12 SRRT AHNAK NCAPD2 HNRNPA0 PRKDC ALDH1B1 TOP2B AHNAK2 | 1.17e-04 | 887 | 112 | 15 | int:ECT2 |
| Interaction | RPS11 interactions | CUL3 EIF2S3B CHD3 DRG1 ITPR3 SND1 ATG3 EIF2S3 PRKDC PRRC2B RAD21 | 1.18e-04 | 505 | 112 | 11 | int:RPS11 |
| Interaction | TOP1 interactions | CUL3 RSF1 CHD3 BANF1 PPP1R8 SRRT PRPF4 HNRNPA0 PRKDC ALDH1B1 DDX39B TOP2B RAI1 | 1.30e-04 | 696 | 112 | 13 | int:TOP1 |
| Interaction | LRRC31 interactions | 1.50e-04 | 205 | 112 | 7 | int:LRRC31 | |
| Interaction | CPPED1 interactions | 1.52e-04 | 19 | 112 | 3 | int:CPPED1 | |
| Interaction | LAIR2 interactions | 1.58e-04 | 49 | 112 | 4 | int:LAIR2 | |
| Interaction | TNFAIP8L1 interactions | 1.58e-04 | 49 | 112 | 4 | int:TNFAIP8L1 | |
| Interaction | CEBPA interactions | CUL3 CHD3 BANF1 DRG1 GMPS PRR12 MED4 SND1 DCD PRPF4 EIF2S3 HNRNPA0 DYNC1LI1 PRKDC TOP2B PRRC2B RAI1 RAD21 | 1.69e-04 | 1245 | 112 | 18 | int:CEBPA |
| Interaction | C1QTNF9B interactions | 1.85e-04 | 51 | 112 | 4 | int:C1QTNF9B | |
| Interaction | CLK1 interactions | 2.24e-04 | 219 | 112 | 7 | int:CLK1 | |
| Interaction | PLOD1 interactions | 2.28e-04 | 292 | 112 | 8 | int:PLOD1 | |
| Interaction | CUL7 interactions | CUL3 COPA CANX EPB41L3 DRG1 SRRT SND1 PRPF4 AHNAK HNRNPA0 AFDN PRKDC DDX39B TOP2B | 2.47e-04 | 845 | 112 | 14 | int:CUL7 |
| Interaction | SPART interactions | 2.75e-04 | 103 | 112 | 5 | int:SPART | |
| Interaction | CDC5L interactions | CUL3 COPA CHD3 EPB41L3 PICALM DRG1 GMPS PPP1R8 AHNAK NCAPD2 DYNC1LI1 MAST1 PRKDC DDX39B | 2.78e-04 | 855 | 112 | 14 | int:CDC5L |
| Interaction | UBE2I interactions | CUL3 TSHZ2 RHOXF2 CANX CHD3 DRG1 SND1 PRKDC DDX39B TOP2B UBFD1 ZNF646 | 2.82e-04 | 654 | 112 | 12 | int:UBE2I |
| Interaction | CCDC8 interactions | COPA CANX CHD3 DRG1 ITPR3 KIAA1671 SND1 AHNAK HNRNPA0 AFDN PRKDC ATP2B1 | 2.90e-04 | 656 | 112 | 12 | int:CCDC8 |
| Interaction | CYP2C9 interactions | 3.01e-04 | 105 | 112 | 5 | int:CYP2C9 | |
| Interaction | VCAM1 interactions | 3.19e-04 | 475 | 112 | 10 | int:VCAM1 | |
| Cytoband | 6q12-q13 | 6.08e-05 | 5 | 114 | 2 | 6q12-q13 | |
| Cytoband | 7q21 | 4.68e-04 | 13 | 114 | 2 | 7q21 | |
| Cytoband | 1p22.3 | 1.37e-03 | 22 | 114 | 2 | 1p22.3 | |
| Cytoband | 13q12.12 | 1.49e-03 | 23 | 114 | 2 | 13q12.12 | |
| Cytoband | 8q24 | 2.21e-03 | 28 | 114 | 2 | 8q24 | |
| Cytoband | 12q14.1 | 2.21e-03 | 28 | 114 | 2 | 12q14.1 | |
| GeneFamily | Collagens | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 2.15e-17 | 46 | 72 | 11 | 490 |
| GeneFamily | Endogenous ligands|C1q and TNF related | 4.73e-05 | 18 | 72 | 3 | 1372 | |
| GeneFamily | Collagens|Collagen proteoglycans | 1.55e-04 | 5 | 72 | 2 | 575 | |
| GeneFamily | PDZ domain containing | 3.50e-04 | 152 | 72 | 5 | 1220 | |
| GeneFamily | Tudor domain containing | 4.27e-04 | 37 | 72 | 3 | 780 | |
| Coexpression | NABA_COLLAGENS | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 2.97e-17 | 43 | 113 | 11 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 3.95e-17 | 44 | 113 | 11 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 2.60e-08 | 270 | 113 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 COL5A3 COL24A1 | 3.14e-08 | 275 | 113 | 11 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A3 COL4A6 C1QTNF8 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 SFTPD C1QTNF9B COL5A3 ADAM22 COL24A1 C1QTNF9 | 8.51e-06 | 1026 | 113 | 16 | M5889 |
| Coexpression | NABA_MATRISOME | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL26A1 SFTPD C1QTNF9B COL5A3 ADAM22 COL24A1 C1QTNF9 | 2.87e-05 | 1008 | 113 | 15 | MM17056 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | GAP43 TSHZ2 FAT3 TPPP CHD3 ADAM22 NAPB MAST1 KCNQ3 ACTL6B PBX3 | 4.57e-05 | 584 | 113 | 11 | M39068 |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_1_DN | 4.65e-05 | 46 | 113 | 4 | M2161 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.97e-08 | 191 | 112 | 8 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.09e-08 | 192 | 112 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.44e-07 | 178 | 112 | 7 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 5.94e-07 | 193 | 112 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 6.36e-07 | 195 | 112 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.29e-07 | 199 | 112 | 7 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 199 | 112 | 7 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.54e-07 | 200 | 112 | 7 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.54e-07 | 200 | 112 | 7 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 3.72e-06 | 164 | 112 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.15e-06 | 179 | 112 | 6 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 181 | 112 | 6 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.77e-06 | 182 | 112 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 7.20e-06 | 184 | 112 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-06 | 185 | 112 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.65e-06 | 190 | 112 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.18e-06 | 192 | 112 | 6 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.18e-06 | 192 | 112 | 6 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.18e-06 | 192 | 112 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.46e-06 | 193 | 112 | 6 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.46e-06 | 193 | 112 | 6 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 9.74e-06 | 194 | 112 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.00e-05 | 195 | 112 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.03e-05 | 196 | 112 | 6 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-05 | 197 | 112 | 6 | 42e49a8ce3118db6c2fd620d70c480b75143c828 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 197 | 112 | 6 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.06e-05 | 197 | 112 | 6 | 4e0c3ea4f4a04a41532806edf3bccf7845c86fa5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 197 | 112 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-05 | 198 | 112 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 198 | 112 | 6 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-05 | 198 | 112 | 6 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.09e-05 | 198 | 112 | 6 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 199 | 112 | 6 | 137ff58897e6ada8a5a70205f66fe9110795506b | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-05 | 200 | 112 | 6 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-05 | 200 | 112 | 6 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 127 | 112 | 5 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.26e-05 | 134 | 112 | 5 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.26e-05 | 134 | 112 | 5 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.26e-05 | 134 | 112 | 5 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.26e-05 | 134 | 112 | 5 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.98e-05 | 142 | 112 | 5 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-05 | 147 | 112 | 5 | c0f62ed3312a33921476e89844486e09326485b7 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.76e-05 | 149 | 112 | 5 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-05 | 164 | 112 | 5 | a764b79a127c8f360af0b79a1da64658badf0dfa | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.28e-05 | 166 | 112 | 5 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 6.83e-05 | 169 | 112 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 170 | 112 | 5 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 172 | 112 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.43e-05 | 172 | 112 | 5 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.43e-05 | 172 | 112 | 5 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 172 | 112 | 5 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 7.84e-05 | 174 | 112 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 175 | 112 | 5 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-05 | 176 | 112 | 5 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.50e-05 | 177 | 112 | 5 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.73e-05 | 178 | 112 | 5 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 179 | 112 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.20e-05 | 180 | 112 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.20e-05 | 180 | 112 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.44e-05 | 181 | 112 | 5 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 9.44e-05 | 181 | 112 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.69e-05 | 182 | 112 | 5 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 182 | 112 | 5 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 182 | 112 | 5 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.69e-05 | 182 | 112 | 5 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.69e-05 | 182 | 112 | 5 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.94e-05 | 183 | 112 | 5 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.94e-05 | 183 | 112 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.94e-05 | 183 | 112 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.94e-05 | 183 | 112 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.94e-05 | 183 | 112 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.02e-04 | 184 | 112 | 5 | 7e1a2971321ddcfa00d78d3e3ba7960e532f9392 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-04 | 185 | 112 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 185 | 112 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-04 | 185 | 112 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 185 | 112 | 5 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 186 | 112 | 5 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 186 | 112 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.10e-04 | 187 | 112 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 112 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 112 | 5 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 112 | 5 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 112 | 5 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-04 | 188 | 112 | 5 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 188 | 112 | 5 | bf77e59b9001c7f7ca17f81073f935f281a25a1f | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 188 | 112 | 5 | b2472a294b25fc2f0da7f18519fdcb9ca166c6f0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 188 | 112 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-04 | 188 | 112 | 5 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.16e-04 | 189 | 112 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-04 | 189 | 112 | 5 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-04 | 189 | 112 | 5 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-04 | 189 | 112 | 5 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 189 | 112 | 5 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-04 | 190 | 112 | 5 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-04 | 190 | 112 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| Computational | Neighborhood of PSMC2 | 8.39e-05 | 115 | 68 | 6 | MORF_PSMC2 | |
| Computational | Neighborhood of RAB1A | 2.07e-04 | 193 | 68 | 7 | MORF_RAB1A | |
| Computational | Neighborhood of PRKAR1A | 2.77e-04 | 143 | 68 | 6 | MORF_PRKAR1A | |
| Computational | Neighborhood of RAC1 | 3.68e-04 | 212 | 68 | 7 | MORF_RAC1 | |
| Computational | Neighborhood of MTA1 | 4.32e-04 | 101 | 68 | 5 | MORF_MTA1 | |
| Drug | GK-101 | 6.20e-12 | 36 | 110 | 8 | CID000161853 | |
| Drug | AC1LAKND | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 1.68e-11 | 62 | 110 | 9 | CID000470146 |
| Drug | khellin | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 AVIL ACTL6B TOP2B | 4.06e-11 | 171 | 110 | 12 | CID000003828 |
| Drug | Madecassol | 5.14e-11 | 46 | 110 | 8 | CID000108062 | |
| Drug | BAPN | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 5.96e-11 | 71 | 110 | 9 | CID000001647 |
| Drug | d-indobufen | 1.04e-10 | 50 | 110 | 8 | CID000044562 | |
| Drug | hydroxylysine | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 SFTPD COL24A1 | 1.31e-10 | 109 | 110 | 10 | CID000001029 |
| Drug | ridogrel | 1.45e-10 | 52 | 110 | 8 | CID005362391 | |
| Drug | NSC49633 | 1.70e-10 | 53 | 110 | 8 | CID000023340 | |
| Drug | halofuginone lactate | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 3.12e-10 | 85 | 110 | 9 | CID000062891 |
| Drug | 4-hydroxyproline | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 5.79e-10 | 91 | 110 | 9 | CID000000825 |
| Drug | PCR 4099 | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 MAST1 | 1.45e-09 | 139 | 110 | 10 | CID000002806 |
| Drug | ticlopidine | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 1.77e-09 | 103 | 110 | 9 | CID000005472 |
| Drug | malotilate | 1.90e-09 | 71 | 110 | 8 | CID000004006 | |
| Drug | AC1NMZ1B | 2.96e-09 | 75 | 110 | 8 | CID005034185 | |
| Drug | strontium ranelate | 3.66e-09 | 77 | 110 | 8 | CID006918182 | |
| Drug | Tranilast sodium | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 4.72e-09 | 115 | 110 | 9 | CID000005527 |
| Drug | DMSe | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL5A3 COL24A1 | 1.59e-08 | 132 | 110 | 9 | CID000020796 |
| Drug | pirfenidone | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 2.35e-08 | 138 | 110 | 9 | CID000040632 |
| Drug | DL-penicillamine | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 2.50e-08 | 139 | 110 | 9 | CID000004727 |
| Drug | candesartan cilexetil | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL24A1 ACTL6B | 3.61e-08 | 145 | 110 | 9 | CID000002540 |
| Drug | AC1L1C2F | 6.25e-08 | 110 | 110 | 8 | CID000001711 | |
| Drug | PPACK | 7.71e-08 | 113 | 110 | 8 | CID003036757 | |
| Drug | AC1L9732 | 8.26e-08 | 114 | 110 | 8 | CID000439300 | |
| Drug | Selara | 1.69e-07 | 125 | 110 | 8 | CID000150310 | |
| Drug | AC1Q6PCP | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 SLC12A1 | 1.77e-07 | 230 | 110 | 10 | CID000005267 |
| Drug | AC1L1DD6 | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 2.20e-07 | 179 | 110 | 9 | CID000002299 |
| Drug | colchine | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 PVALB ACTL6B TOP2B | 3.46e-07 | 383 | 110 | 12 | CID000002833 |
| Drug | foscarnet | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL24A1 ACTL6B | 3.65e-07 | 190 | 110 | 9 | CID000003414 |
| Drug | prostacyclin sodium salt | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 ECE1 COL24A1 ACTL6B | 3.82e-07 | 250 | 110 | 10 | CID000000159 |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.22e-06 | 162 | 110 | 8 | CID000072363 | |
| Drug | silibinin | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 PRKDC | 1.26e-06 | 285 | 110 | 10 | CID000005213 |
| Drug | losartan | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 SLC12A1 ACTL6B | 2.24e-06 | 378 | 110 | 11 | CID000003961 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 SFTPD COL24A1 DMKN | 2.99e-06 | 314 | 110 | 10 | CID000447989 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 3.87e-06 | 189 | 110 | 8 | CID000001413 | |
| Drug | chondroitin sulfate | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 BANF1 COL24A1 PVALB | 5.23e-06 | 413 | 110 | 11 | CID000024766 |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; HL60; HT_HG-U133A | 5.25e-06 | 197 | 110 | 8 | 2934_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 5.25e-06 | 197 | 110 | 8 | 1678_UP | |
| Drug | hyaluronan | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 5.37e-06 | 263 | 110 | 9 | CID000024759 |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; HL60; HG-U133A | 5.45e-06 | 198 | 110 | 8 | 1976_UP | |
| Drug | AC1L1KMJ | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 CABLES1 COL24A1 ACTL6B | 1.97e-05 | 476 | 110 | 11 | CID000030956 |
| Drug | AC1L18QD | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 COL19A1 COL24A1 | 2.89e-05 | 325 | 110 | 9 | CID000000213 |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; PC3; HT_HG-U133A | 4.16e-05 | 192 | 110 | 7 | 6714_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.30e-05 | 193 | 110 | 7 | 6716_DN | |
| Drug | Ethamivan [304-84-7]; Down 200; 18uM; HL60; HG-U133A | 4.44e-05 | 194 | 110 | 7 | 1730_DN | |
| Drug | 5194442; Down 200; 20uM; PC3; HT_HG-U133A | 4.44e-05 | 194 | 110 | 7 | 6553_DN | |
| Drug | SC-560; Down 200; 10uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 6870_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 4382_UP | |
| Drug | Iodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 4848_UP | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 6797_DN | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 6748_UP | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 6826_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 3866_UP | |
| Drug | Felbinac [5728-52-9]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 3398_UP | |
| Drug | NC-4 | 6.03e-05 | 44 | 110 | 4 | CID006420119 | |
| Drug | LMWH | COL4A3 COL4A6 COL6A3 COL7A1 COL9A1 COL11A2 COL12A1 CEL ITPR3 COL24A1 KCNQ3 ACTL6B | 8.77e-05 | 663 | 110 | 12 | CID000000772 |
| Drug | Emetine dihydrochloride [316-42-7]; Down 200; 7.2uM; HL60; HT_HG-U133A | 1.52e-04 | 165 | 110 | 6 | 2145_DN | |
| Drug | 1h00 | 1.56e-04 | 56 | 110 | 4 | CID000445950 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; HL60; HT_HG-U133A | 1.85e-04 | 171 | 110 | 6 | 2429_DN | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | skin disease (implicated_via_orthology) | 3.90e-05 | 3 | 107 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | Bethlem myopathy (is_implicated_in) | 7.78e-05 | 4 | 107 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 7.78e-05 | 4 | 107 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 7.78e-05 | 4 | 107 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 7.78e-05 | 4 | 107 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 7.78e-05 | 4 | 107 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy 1 | 7.78e-05 | 4 | 107 | 2 | C0410179 | |
| Disease | Stickler syndrome | 1.29e-04 | 5 | 107 | 2 | cv:C0265253 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.42e-04 | 28 | 107 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | hypopituitarism (implicated_via_orthology) | 1.94e-04 | 6 | 107 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | urate measurement | COL7A1 GAP43 MFHAS1 CHD3 EPB41L3 MED4 ZNHIT6 SLC12A1 FMN2 KDM4B PRRC2B | 4.12e-04 | 895 | 107 | 11 | EFO_0004531 |
| Disease | leukodystrophy (implicated_via_orthology) | 4.61e-04 | 9 | 107 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | Sensory hearing loss | 7.01e-04 | 11 | 107 | 2 | C1691779 | |
| Disease | collagen disease (implicated_via_orthology) | 8.40e-04 | 12 | 107 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | CEL MFHAS1 ZNF366 IST1 CHD3 ECE1 SRRT AHNAK ENTPD6 FMN2 RAI1 | 1.16e-03 | 1015 | 107 | 11 | EFO_0004533 |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis | 1.71e-03 | 17 | 107 | 2 | EFO_0004276, EFO_0004775 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.71e-03 | 17 | 107 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | uric acid measurement | 1.73e-03 | 610 | 107 | 8 | EFO_0004761 | |
| Disease | Myeloid Leukemia | 1.92e-03 | 18 | 107 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.92e-03 | 18 | 107 | 2 | C0023466 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 2.14e-03 | 19 | 107 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Craniofacial Abnormalities | 2.54e-03 | 156 | 107 | 4 | C0376634 | |
| Disease | Down syndrome (is_marker_for) | 2.87e-03 | 22 | 107 | 2 | DOID:14250 (is_marker_for) | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.14e-03 | 23 | 107 | 2 | C0018784 | |
| Disease | unipolar depression, neuroticism measurement | 3.41e-03 | 24 | 107 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | chronic obstructive pulmonary disease | 3.62e-03 | 688 | 107 | 8 | EFO_0000341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKGGAADVDGRLAAG | 1041 | P55196 | |
| AGGFEDEGEDKKVRG | 501 | P50548 | |
| KAGLPGLEEGGKDSL | 716 | Q5RHP9 | |
| KLVERAGAGAAGAGE | 71 | A0A494C0Y3 | |
| KLVERAGAGAAGAGE | 71 | A0A494C0N9 | |
| GAEGTGDAVLGEKVL | 201 | Q92667 | |
| GVLKGELSDLGAEDG | 546 | Q92667 | |
| GRAKIGVIEGDKEAA | 201 | O75366 | |
| KGEDGKVGVSGDVGL | 1111 | Q14031 | |
| GLMGEDGIKGQKGDI | 321 | Q01955 | |
| GPKGELALSGEKGDQ | 581 | Q01955 | |
| AAGGDGAEAPAKKDV | 21 | Q13838 | |
| AEEGGGLELEGDKEK | 46 | O94805 | |
| KESGNGRELGEDGLK | 486 | P30837 | |
| LLKGGGVNEFGKTDL | 351 | Q9P0K1 | |
| FEGGEVSLEGGKVKG | 5801 | Q09666 | |
| GVGIGGESADKKDEE | 171 | Q8WYQ5 | |
| GFVEGVNKKLGLLGD | 31 | P19835 | |
| GDGTNDGPALKKADV | 796 | P20020 | |
| KKIIETVAEGGGELG | 271 | Q9NT62 | |
| KQEEVGGVKEEAGGL | 811 | Q7Z5J4 | |
| GEGNDGGILDDKLIS | 221 | O60216 | |
| KGSGKGEEVEAGAAK | 1131 | Q14573 | |
| AVAAGLGLEAGSKEE | 396 | P48050 | |
| GGGVALKKEIGLVSA | 31 | Q9UHI5 | |
| GLGLGDAKDITVKGL | 6 | Q9H2P9 | |
| GGKEEAAGDGPVSEK | 561 | Q6GQQ9 | |
| GSDDEKTGLKIVGNG | 41 | Q9Y3P9 | |
| GADGDGRKQDIGDIL | 36 | P40426 | |
| AAKRLGIEDAAGLGG | 186 | Q96PR1 | |
| LKKGENGVPGEDAGL | 176 | Q96S90 | |
| LDLPGIIEGAKDGKG | 116 | Q9Y295 | |
| LGKAVSEGAEEAKLG | 156 | Q9BY89 | |
| GDGGAKALAEALKVN | 791 | Q7RTR2 | |
| KLLLGTSGEGKAEGE | 751 | Q9Y4C4 | |
| GGDREGVEKVLGELS | 651 | Q9UBC5 | |
| ADKDGTLLLEGGGRD | 61 | O43525 | |
| AGKNVLLLGEDGAGK | 66 | Q9Y6G9 | |
| LEEGGKGKEAAGSVR | 306 | Q5T3I0 | |
| KSEIKILSIGGGAGE | 51 | P50135 | |
| LDGVKGDLLIDIGSG | 51 | P40261 | |
| FKGDIGVKGDRGEVG | 746 | P13942 | |
| AVGGLGKLGKDAVED | 76 | P81605 | |
| AGAALLEEAGGSVKE | 396 | O94953 | |
| SGEKEKERLGGGLGV | 6 | Q9NPJ6 | |
| EEKVAGKREGLGGLT | 746 | Q9Y2H9 | |
| GGATADSLGGKEEKR | 211 | P09630 | |
| GEKGERGADGKVEAK | 71 | P0C862 | |
| RGADGKVEAKGIKGD | 76 | P0C862 | |
| GDSKLENAGGDLKDG | 6 | P49915 | |
| EIIGLEGVELGADGK | 381 | Q8TDN4 | |
| SGLKGEKGDRGDIAS | 2886 | Q99715 | |
| ALSEGVGKAIGKEAG | 46 | Q6E0U4 | |
| EKGEQGEKGDPALAG | 341 | Q14993 | |
| EDVILGELLGKGNFG | 561 | P16591 | |
| EGETGDLGKREDVKG | 1666 | Q12873 | |
| GKGGALAADIDIDTV | 826 | P53621 | |
| PVKKEDGSEVGVGGA | 566 | Q13618 | |
| GEKGEVGEIGLDGLD | 2101 | P12111 | |
| HDGKIIALGGLDSGK | 3601 | Q8TDW7 | |
| EEGTGLTGIKEIGDG | 46 | Q9NWK9 | |
| LTGIKEIGDGEEGSG | 51 | Q9NWK9 | |
| GEKGERGADGKVEAK | 71 | B2RNN3 | |
| RGADGKVEAKGIKGD | 76 | B2RNN3 | |
| GLKKAADGAAEPGVV | 456 | P27824 | |
| EILKGEKGEAGVRGR | 66 | P60827 | |
| IDVGFTDDVKKGGPG | 196 | P53990 | |
| IVGDKGEKGARGLDG | 476 | P20849 | |
| GSAGLKGDKGDSAVI | 2511 | Q02388 | |
| VQLGKLLGGGDEEAI | 286 | P42892 | |
| VDDLKGGVAGGSILK | 271 | Q2VIR3 | |
| GSLAGIGEVLGKKLE | 21 | O75531 | |
| GKLKRSAGDALHEGG | 6 | Q9NZ56 | |
| KGKGAGGSREDVLDS | 86 | Q9NZ56 | |
| DDIKEADGGGVGRGK | 1036 | Q96T23 | |
| GAGEKGAKGEPAVIE | 371 | P25940 | |
| RGLQGEKGEKGEDGF | 721 | P25940 | |
| PGVKGEEGEKAATAE | 346 | Q96A83 | |
| GKEGSALTEGAKEEG | 891 | Q9Y2J2 | |
| EVDIEAKDGGGLSGK | 316 | Q9Y5E6 | |
| GKVLKAVEGEGGVRS | 646 | Q5HYA8 | |
| EKMGGEDDELKGLLG | 141 | Q12972 | |
| IKGIPKLDDANDAGG | 456 | Q02880 | |
| ILGGVEGQPAKDGKE | 306 | O75354 | |
| DGTEKGKFLALDLGG | 521 | Q2TB90 | |
| EAPVADGVEKKGEGT | 71 | P17677 | |
| ERLAKGESGILGKDG | 41 | O43172 | |
| GESGILGKDGLKAGI | 46 | O43172 | |
| LGKDGLKAGIEAGNI | 51 | O43172 | |
| DSKGDVGLGLVKEGL | 846 | Q7KZF4 | |
| EEESGGIRGLFKKAG | 851 | Q13621 | |
| AGEKLKSAGAQGGEE | 56 | P0C7M4 | |
| KGVGAGEEKDGAAVS | 81 | Q66K80 | |
| DLIDGGEGRKKSGQT | 101 | Q92535 | |
| LVGEDGAADASKGLG | 661 | Q9ULL5 | |
| DGGGKIDLIEAGAFT | 166 | Q8IYS1 | |
| GEPSKKEEGRAGAGL | 281 | Q9BXP5 | |
| SKAGTGLKGEEVEGA | 521 | Q8IVF2 | |
| IGEALKEDVGPGKAV | 56 | P14550 | |
| GLDGIKELEIGQAGS | 1296 | Q15021 | |
| ESQVKGGGDKPLADG | 666 | Q16281 | |
| GIKGDKGEQGTAGEL | 711 | Q17RW2 | |
| IVDSGGFDELGGLLK | 501 | Q13492 | |
| GEKEIIGGDVEGTKL | 1601 | A4UGR9 | |
| DEESKGLGKENGIGT | 616 | Q9H9J4 | |
| DAGGGAGRELVDLKI | 76 | O14562 | |
| GDKGAKGESGLPDVA | 211 | P35247 | |
| FVGGLKGDVAEGDLI | 101 | Q13151 | |
| LMAAGDKDGDGKIGV | 86 | P20472 | |
| VGAEAEAKGAGEAGL | 971 | Q9BXM0 | |
| GKDGVLRDGDGAVVL | 1356 | O94964 | |
| AAVEEAKVARKGGGL | 486 | Q8N9M5 | |
| DKESGGTGEGLERKD | 751 | O15015 | |
| VDGGLSGASLGEKKE | 1401 | Q5JSZ5 | |
| AGEKLKSAGAQGGEE | 56 | Q9BQY4 | |
| LRIKKSIQGDGEGDG | 281 | Q9H115 | |
| LEDGSKGGGDILKSL | 506 | Q9NRE2 | |
| GLPGDEVDNKVKGAA | 2706 | P78527 | |
| GKGKAGRVDLVDESG | 186 | O94811 | |
| EKRSKGDLGAEGGQE | 676 | Q8N895 | |
| GLDDDGDLKGGNKAA | 151 | O94901 | |
| LIVGKALGEDIGGKR | 96 | Q8WY98 | |
| KEAVAAAGAAGGKGE | 186 | Q9BXU2 | |
| VDDLKGGVAGGSILK | 271 | P41091 |